Alembic Ltd.

Financial

	Alembic	Arvind Smartspaces	AGI Infra
Operational Metrics
Pharmaceutical Sector
Domestic Sales Growth - YoY	1.8 %	n/a	n/a
R&D as a % of Total Sales	0.03 %	n/a	n/a
Financials
5 yr Average ROE	11.71 %	8.18 %	24.15 %
5yr average Equity Multiplier	1.06	3.45	5.04
5yr Average Asset Turnover Ratio	0.06	0.2	0.27
5yr Avg Net Profit Margin	242.13 %	10.66 %	17.62 %
Price to Book	1.22	4.63	8.92
P/E	9.19	23.33	39.44
5yr Avg Cash Conversion Cycle	42.4 Days	468.97 Days	715.85 Days
Inventory Days	234.32 Days	1179.21 Days	904.02 Days
Days Receivable	40.9 Days	4.41 Days	3.49 Days
Days Payable	210.29 Days	787.6 Days	92.2 Days
5yr Average Interest Coverage Ratio	129.14	4.08	7.35
5yr Avg ROCE	4.08 %	12.64 %	28.41 %
5yr Avg Operating Profit Margin	28.41 %	24.34 %	28.21 %
5 yr average Debt to Equity	0.0	0.34	0.67
5yr CAGR Net Profit	-1.95 %	66.06 %	28.19 %
5yr Average Return on Assets	11.03 %	2.23 %	4.89 %
Shareholdings
Promoter Holding	70.88 %	49.96 %	72.94 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-3.86 %	0.0
Change in Mutual Fund Holding (3 Yrs)	-4.24 %	2.3 %	0.0

Business

	Alembic	Arvind Smartspaces	AGI Infra
Product Wise Break-Up	Product Wise Break-Up Real Estate 87.07 Active Pharmaceutical Ingredient (API) 12.91 Real estate 0 Others 0.02	Product Wise Break-Up Real Estate 0 Real Estate 100.0 Active Pharmaceutical Ingredient (API) 0	-
Location Wise Break-Up	Location Wise Break-Up India 98.85 Rest of the World 1.15	Location Wise Break-Up Rest of the World 0 India 100.0	Location Wise Break-Up Rest of the World 0 India 100.0
Operating Profit Break-Up	Operating Profit Break-Up Real Estate 93.17 API 6.83	-	-
Asset Break-Up	Asset Break-Up Others 100	-	-